Tech Transfer Initiative Aims To Speed Development Of MS Treatments
Main Category: Multiple SclerosisArticle Date: 10 Dec 2007 - 2:00 PDT
| Patient / Public: | ![]() |
4.5 (8 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
The National Multiple Sclerosis Society last week announced the creation of Fast Forward LLC, a technology transfer initiative aimed at translating promising laboratory discoveries into effective new treatments for MS sufferers. A wholly owned subsidiary of the society, Fast Forward intends to partner with start-up and existing companies to develop new therapies or repurpose existing drugs to treat the crippling condition.
The new entity is currently evaluating business proposals and plans to make initial investments in early 2008. The National MS Society is one of only a handful of health-related foundations and nonprofit organizations in recent years to create technology transfer programs, driven in part by the lack of progress in drug development for certain diseases. Other examples include the Cystic Fibrosis Foundation and the Leukemia & Lymphoma Society. According to Timothy Coetzee, executive director of Fast Forward, some private companies are hesitant to invest the time and money needed to develop MS-related treatments because the potential market is considered relatively small. The worldwide market for MS-related therapies is estimated at $4 billion annually.
"It is our responsibility to find innovative and effective ways to fill the gap between university knowledge and commercial treatments and to meet our commitment to people with MS," Coetzee said. "We won't hit home runs on every investment, but when we do, it will change the future for people living with this disease." Fast Forward has already secured $4.5 million of the $30 million it plans to raise during the next six years to fund the investments, and it expects to reinvest revenues generated from royalty payments on the drugs its efforts help develop and commercialize.
Go to this link and here.
Technology Transfer Tactics
Visit our multiple sclerosis section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/91231.php>
APA
http://www.medicalnewstoday.com/releases/91231.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




